More than a fortnight has elapsed since a Japanese company, Daiichi Sankyo, announced its plan to acquire a controlling stake in Ranbaxy, India's largest drug multinational.

<tr><td><p class='TableClas'></p><P class='TableClas'><DIV CLASS=rightDiv><script language="JavaScript">
		google_ad_client = 'businessstandard';
		//google_ad_client = 'ca-businessstandard_js';
		google_ad_width = 200;
		google_ad_height = 200;
		google_ad_format = "200x200_as";
		google_ad_type = "text";
		google_ad_channel = "";
		//google_color_border = "FFFFFF";
		google_color_border = "F7F7F7";
		//google_color_bg = "FFFFFF";
		google_color_bg = "ffffff";
		//google_color_link = "639ACE";
		google_color_link = "0253B7";
		google_color_text = "000000";
		google_color_url = "D63431";
		//google_skip = adsenseSkip;
		</script> 
		<script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
		</script> </DIV><p class='TableClas'>Of course, nothing much was expected from Congress leaders, who are understandably preoccupied with graver issues of national and international significance 

P>More than a fortnight has elapsed since a Japanese company, Daiichi Sankyo, announced its plan to acquire a controlling stake in Ranbaxy, India's largest drug multinational.

A K Bhattacharya: The myth about India`s politicians

NEW DELHI DIARY

More From This Section

Ajai Shukla: Rafale's July take-off

Alokananda Chakraborty: It is okay to procrastinate

Sukumar Mukhopadhyay: GST - 'Paradise lost' from fractured design

Daniel Gros: Saving Europe's social model

Explore News